arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Adicet Bio, Inc.

ACET

$8.06 ▲ +0.07 (+0.88%) at close

10 Visible periods

21 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Adicet Bio, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $55.5M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -76.7% ↘

FCF / Share $-14.07 ↗

Trailing P/E —

Price / Book 0.5x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

10-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-116.80M

— +0.3% —

FCF / Share Free cash flow per share

$-14.07

↑ +17.3% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Financial Health ↓

Cash Quality ↓

Dividend History

Dividend / share · sourced from SEC filings

$0.00 Latest / share

FY 2016

FY 2017

$0.00

FY 2018

$0.00

FY 2019

$0.00

FY 2020

FY 2021

FY 2022

FY 2023

FY 2024

FY 2025

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Jul 4, 2016 10-K ↗
EPS Growth YoY (%)	20.5% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-544.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-94.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	15.0% Good Good Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—
Net Income Growth YoY (%)	0.3% Caution ↑ Caution Improving Year-over-year change in net income	17.9% Good ↑ Good Improving Year-over-year change in net income	-104.4% Weak ↓ Weak Declining Year-over-year change in net income	-12.6% Weak ↑ Weak Improving Year-over-year change in net income	-69.0% Weak ↓ Weak Declining Year-over-year change in net income	-30.4% Weak ↓ Weak Declining Year-over-year change in net income	25.2% Excellent Excellent Year-over-year change in net income	-11.4% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	17.3% Good ↑ Good Improving Year-over-year change in free cash flow	-646.4% Weak ↓ Weak Declining Year-over-year change in free cash flow	-52.3% Weak ↓ Weak Declining Year-over-year change in free cash flow	27.7% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	64.4% Excellent Excellent Year-over-year change in free cash flow	56.9% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Jul 4, 2016 10-K ↗
Effective Tax Rate (%) (%)	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	7.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
FCF / Net Income (x)	0.83x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.03x Fair → Fair Stable Free cash flow relative to reported net income Optimal: > 1x	1.16x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.03x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.33x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Jul 4, 2016 10-K ↗
Return on Invested Capital (%)	-76.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-68.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-89.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-33.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	52.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-38.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	59.1% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-63.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-57.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-73.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-18.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-25.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-38.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-36.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-34.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-73.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-589%)	-62.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-518%)	-83.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-659%)	-23.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-259%)	-20.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-236%)	-33.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-323%)	46.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+211%)	-36.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-341%)	105.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+605%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Jul 4, 2016 10-K ↗
Interest Coverage (x)	-3392.06x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-31903.75x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-6081.52x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-906.89x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-349.05x Weak Weak Operating income divided by interest expense Optimal: > 5x	-292.47x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—
Net Debt (USD)	$-38.92M	$-56.49M	$-159.71M	$-257.66M	$-277.54M	$-84.33M	$-10.61M	$-7.04M	$-53.35M	$0.00

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Jul 4, 2016 10-K ↗
Basic EPS, GAAP (USD)	$-16.95	$-21.33	$-3.31	$-1.70	$-2.00	—	—	—	—	—
Free Cash Flow per Share (USD)	$-14.07	$-17.03	$-2.28	$-1.50	$-2.07	$-5.81	$-13.48	—	—	—
Dividend per Share (USD)	—	—	—	—	—	$0.00	$0.00	$0.00	—	—
Book Value per Share (USD)	$16.61	$36.16	$3.93	$6.81	$7.63	$5.58	$-28.00	$29.95	$-45.50	—
Tangible Book Value per Share (USD)	$16.61	$36.16	$3.93	$6.35	$7.14	$4.56	$-28.00	$29.95	$-45.50	—
Basic Weighted Avg Shares (shares)	6.89M	5.49M	43.04M	41.08M	30.95M	7.32M	2.15M	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Jul 4, 2016 10-K ↗
Working Capital (USD)	$139.40M	$160.74M	$142.99M	$241.33M	$266.12M	$77.86M	$49.32M	$103.82M	$49.65M	—
Total Equity (USD)	$159.21M	$186.61M	$170.18M	$292.34M	$303.13M	$109.83M	$-60.37M	$104.20M	$-31.93M	$0.00

📋 What is driving earnings? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Jul 4, 2016 10-K ↗
Depreciation Expense (USD)	$6.38M	$6.47M	$6.10M	—	—	—	—	$80.00K	$5.00K	—
Net Income, GAAP (USD)	$-116.80M	$-117.12M	$-142.66M	$-69.79M	$-62.00M	$-36.68M	$-28.14M	$-37.61M	$-33.78M	—
Operating Cash Flow (USD)	$-95.25M	$-92.38M	$-93.72M	$-44.77M	$-51.05M	$-41.55M	$-27.88M	$-35.53M	$-10.98M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 10 years · 38 quarters

Adicet Bio, Inc.

Analytical Summary

10-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ACET with peers